LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5.
Wang TT, Zhang LL, Li FB, Zhang J, Zhang ZB, Mi DZ, Sun J, Zhang HY, Wang CY, Chen YH, Chen CS.
Wang TT, et al. Among authors: zhang zb, zhang j, zhang ll, zhang hy.
Acta Pharmacol Sin. 2024 Oct 8. doi: 10.1038/s41401-024-01361-1. Online ahead of print.
Acta Pharmacol Sin. 2024.
PMID: 39379684